Copertina

Desmoplastic melanoma in Sweden in 2009–2022: A population‐based registry study demonstrating distinctive tumour characteristics, incidence and survival trends

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Yodit Girmay, Francesca Portelli, Rasmus Mikiver, Jan Lapins, Karolin Isaksson, Hildur Helgadottir
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Journal of the European Academy of Dermatology and Venereology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Declining invasive and rising in situ melanoma incidence trends in Iceland: A nationwide cohort study
di: Sierra Thomas, et al.
Pubblicazione: (2024)

Pregnancy‐associated melanoma: A distinct entity requiring vigilance
di: Maria Kostaki, et al.
Pubblicazione: (2026)

Identification of two molecularly and prognostically distinct subtypes in acral melanoma using network prediction method
di: Mingzhu Yin, et al.
Pubblicazione: (2024)

Spatial transcriptomic analysis of tumour–immune cell interactions in melanoma arising from congenital melanocytic nevus
di: Youngkyoung Lim, et al.
Pubblicazione: (2024)

Baseline characteristics of atopic eczema patients enrolled in seven European registries united in the TREatment of ATopic eczema ( TREAT ) registry taskforce
di: A. H. Musters, et al.
Pubblicazione: (2025)

Trends in cutaneous melanoma mortality and incidence in European Union 15+ countries between 1990 and 2019
di: Xingyue M. Wang, et al.
Pubblicazione: (2025)

Number of melanoma deaths over time in relation to tumour thickness: Data from a Melanoma Unit Reference Center
di: I. A. Stratigos, et al.
Pubblicazione: (2024)

Switching PD‐1 to BRAF + MEK inhibition improves recurrence‐free survival in patients receiving a second course of adjuvant melanoma therapy
di: Katharina Schumann, et al.
Pubblicazione: (2025)

Adjuvant treatment for acral melanoma
di: Takaya Komori, et al.
Pubblicazione: (2026)

Cutaneous melanoma in adolescents and young adults
di: Alessandra Buja, et al.
Pubblicazione: (2024)

Prevalence of prurigo nodularis in Sweden
di: A. Antelmi, et al.
Pubblicazione: (2024)

Melanocytic clefting is associated with melanoma on LC ‐ OCT
di: J. Pérez‐Anker, et al.
Pubblicazione: (2025)

Advancing AI models for enhanced melanoma diagnosis
di: François Kuonen, et al.
Pubblicazione: (2025)

Moles and melanomas on tattoos: Where we are in 2025
di: Nicolas Kluger
Pubblicazione: (2025)

The quest for missing risk factors to predict melanoma
di: M. Wakkee, et al.
Pubblicazione: (2025)

Precision medicine in cutaneous melanoma—A comprehensive review
di: Markus Reitmajer, et al.
Pubblicazione: (2025)

MAPK activity as a surrogate of acral melanoma immunogenicity?
di: Rastine Merat
Pubblicazione: (2025)

Prevention of amputation by neoadjuvant therapy with pembrolizumab in acrolentiginous melanoma
di: Inga Hansen, et al.
Pubblicazione: (2024)

Control of rapidly progressing melanoma metastases during pregnancy
di: Isabel Wolff, et al.
Pubblicazione: (2025)

Family history in melanoma risk: Revisiting criteria for surveillance
di: Annemiek Leeman, et al.
Pubblicazione: (2025)

Diving beyond surface perceptions of melanoma diagnosis and screening
di: Efthymia Soura, et al.
Pubblicazione: (2024)

Effect of patient‐contextual skin images in human‐ and artificial intelligence‐based diagnosis of melanoma: Results from the 2020 SIIM‐ISIC melanoma classification challenge
di: Nicholas R. Kurtansky, et al.
Pubblicazione: (2024)

Exploring blood cell biomarkers in melanoma patients receiving adjuvant anti‐ PD ‐1 immunotherapy
di: Renan de Jesus Teixeira, et al.
Pubblicazione: (2025)

Therapeutic transitions and equity gaps in atopic eczema: Lessons from the TREAT registry collaboration
di: Bi‐Yu Gao, et al.
Pubblicazione: (2025)

Disagreement between physicians' and patients' assessment of disease activity in psoriasis: The SPEECH registry study
di: Yuxiong Jiang, et al.
Pubblicazione: (2024)

Age matters: Rethinking SLNB's reliability in melanoma mortality prediction
di: Christoffer Gebhardt
Pubblicazione: (2024)

Pregnancy‐associated melanoma epidemiology: A multicentre European study
di: Maria Kostaki, et al.
Pubblicazione: (2025)

Benefit of immune checkpoint inhibitors as adjuvant treatment for acral melanomas
di: Damien Sanogo, et al.
Pubblicazione: (2025)

Acral melanoma: Molecular subtyping as a gateway to precision medicine
di: Emi Dika, et al.
Pubblicazione: (2025)

Treatment of moderate‐to‐severe atopic dermatitis with baricitinib: Results from an interim analysis of the TREATgermany registry
di: Stephan Traidl, et al.
Pubblicazione: (2024)

Efficacy and safety of lebrikizumab in atopic dermatitis over 24 weeks: An analysis from the BIOREP registry
di: Filip Rob, et al.
Pubblicazione: (2025)

Melanocytic clefting in melanoma: Reassessing its role in diagnostic decision‐making
di: Shiuan‐Chih Chen, et al.
Pubblicazione: (2025)

Genetic susceptibility in early‐onset melanoma: An observational Greek cohort study
di: Eftychia Chatziioannou, et al.
Pubblicazione: (2025)

Early termination does not negatively impact the outcome of adjuvant immunotherapy in melanoma
di: Dirk Tomsitz, et al.
Pubblicazione: (2025)

Melanosis and isolated follicular vitiligo during checkpoint inhibitors for metastatic melanoma
di: Valentine Salvestrini, et al.
Pubblicazione: (2024)

Anti‐aging trends in Australia
di: Leona Yip
Pubblicazione: (2024)

Revisiting the evidence: UV exposure, melanoma and the need for smarter public health strategies
di: Efthymia Soura, et al.
Pubblicazione: (2025)

Enhancing HFUS accuracy in melanoma assessment: The role of artificial intelligence and statistical precision
di: I. Chen, et al.
Pubblicazione: (2024)

The unmet potential of patient context in melanoma AI : Addressing design and data biases
di: Yukun Wen, et al.
Pubblicazione: (2025)

Microsatellitosis of cutaneous melanomas in wide local excision specimens after excisional biopsy
di: Pablo Vargas‐Mora, et al.
Pubblicazione: (2025)